Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Molecular Characterization of Diffuse Large B-Cell Lymphoma Associated to Hepatitis C Virus Infection

Blood (2021) 138 (Supplement 1): 2402.

DOI: https://doi.org/10.1182/blood-2021-152636

Published: 2021

Journal Articles

Targeted Next Generation Sequencing Reveals Molecular Heterogeneity in Non-CLL Clonal B-Cell Lymphocytosis

Irene Defrancesco, Silvia Zibellini, Emanuela Boveri, Marco Frigeni, Virginia Valeria Ferretti, Ettore Rizzo, Francesca Capuano, Arturo Bonometti, Chiara Candido, Sara Rattotti, Elena Flospergher, Fabio Bergamini, Caterina Zerbi, Marco Paulli, Marzia Varettoni, Luca Arcaini

Blood (2019) 134 (Supplement_1): 1502.

DOI: https://doi.org/10.1182/blood-2019-130233

Published: 2019

Journal Articles

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Blood (2019) 134 (10): 798–801.

DOI: https://doi.org/10.1182/blood.2019001088

Published: 2019

Includes: Supplemental data

Journal Articles

Early Progression As a Predictor of Survival in Marginal Zone Lymphomas: An Analysis from the Prospective International NF10 Study By Fondazione Italiana Linfomi

Blood (2018) 132 (Supplement 1): 393.

DOI: https://doi.org/10.1182/blood-2018-99-115827

Published: 2018

Journal Articles

Molecular Subtypes of Splenic Marginal Zone Lymphoma (SMZL) Are Associated with Distinct Pathogenic Mechanisms and Outcomes - Interim Analysis of the IELSG46 Study

Francesca Guidetti, Alessio Bruscaggin, PhD, Marco Frigeni, MD, Valeria Spina, PhD, Lodovico Terzi di Bergamo, Adalgisa Condoluci, MD, Gabriela Forestieri, Francesco Bertoni, MD, Luciano Cascione, PhD, Manuela Mollejo, Véronique Meignin, Alexandra Traverse-Glehen, MD PhD, Julia T Geyer, MD, Alessandro Broccoli, Alessandra Tucci, Silvia Bea, Renzo Boldorini, Gustavo Tapia, Antonino Maiorana, Maria Gomes da Silva, MD, Juan F. Garcia, Felicitas Hitz, Michele Merli, MD, Giorgio A. Vanini, Urban Novak, Francesco Piazza, Stefano Pizzolitto, Sascha Dietrich, Liliana Devizzi, Marco Ladetto, Maurilio Ponzoni, MD, Alessandro Rambaldi, MD, Paolo Corradini, Corrado Tarella, Elisa Santambrogio, Umberto Vitolo, Francesco Zaja, Francesco Passamonti, MD, Alexandar Tzankov, Sergio Cogliatti, Carlos Montalban, Roberto Marasca, MD, Laurence de Leval, MD, Carlo Visco, Maria Joao Baptista, PhD PharmD, Vincenzo Canzonieri, Estella Matutes, Fabio Facchetti, Marco Paulli, Elias Campo, David Oscier, Elena Sabattini, Pier Luigi Zinzani, MD, Govind Bhagat, Stefano A. Pileri, MD PhD, Giorgio Inghirami, MD, Gianluca Gaidano, MD PhD, Gilles Salles, MD PhD, Catherine Thieblemont, MD, Miguel A. Piris, Franco Cavalli, MD, Emanuele Zucca, Luca Arcaini, MD, Davide Rossi, MD PhD

Blood (2018) 132 (Supplement 1): 922.

DOI: https://doi.org/10.1182/blood-2018-99-115958

Published: 2018

Journal Articles

Hepatitis B Virus Associated B-Cell Non-Hodgkin Lymphoma in Non-Endemic Areas

Marine Lemaitre, Pauline Brice, MD, Marco Frigeni, MD, Catherine Thieblemont, MD, Luca Arcaini, MD, Caroline Besson, MD PhD

Blood (2018) 132 (Supplement 1): 4228.

DOI: https://doi.org/10.1182/blood-2018-99-120349

Published: 2018

Journal Articles

Real Life Data on Clinical Aspects and Treatment of Marginal Zone Lymphoma: An Analysis from the NF10 Project, an International, Prospective, Observational Study of the Fondazione Italiana Linfomi

Blood (2017) 130 (Supplement 1): 1493.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1493.1493

Published: 2017

Journal Articles

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection

Blood (2016) 128 (21): 2527–2532.

DOI: https://doi.org/10.1182/blood-2016-05-714667

Published: 2016

Includes: Supplemental data

Journal Articles

Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era

Chiara Rusconi, MD, Maria Luisa Guerrera, MD, Alessandra Tedeschi, MD, Michelle Zancanella, MD, Manuel Gotti, MD, Michele Nichelatti, Sara Rattotti, MD, Lara Crucitti, MD, Marco Frigeni, Erika Meli, MD, Paola Picardi, MD, Anna Maria Frustaci, MD, Roberta Sciarra, Vittorio Ruggero Zilioli, MD, Periana Minga, MD, Marco Paulli, Roberto Cairoli, MD, Luca Arcaini

Blood (2015) 126 (23): 5098.

DOI: https://doi.org/10.1182/blood.V126.23.5098.5098

Published: 2015

Journal Articles

Pattern of Care in Indolent Non Follicular Lymphoma: A Report from NF10 Project, an International, Prospective, Observational Study Coordinated By the Fondazione Italiana Linfomi

Blood (2015) 126 (23): 2686.

DOI: https://doi.org/10.1182/blood.V126.23.2686.2686

Published: 2015

Journal Articles

Childhood myelodysplastic syndrome associated with an acquired Bernard-Soulier–like platelet dysfunction

Marco Frigeni, Monica Galli

Blood (2014) 124 (16): 2609.

DOI: https://doi.org/10.1182/blood-2014-08-587832

Published: 2014

Journal Articles

The Long-Term Outcome Of Adult Patients With Acute Myeloid Leukemia NPM+ and FLT3/ITD- Is Not Significantly Improved By The Application Of An Allogeneic Stem Cell Transplantation

Tamara Intermesoli, MD, Marco Frigeni, MD, Elena Oldani, BiolSC, Pamela Zanghì, BiolSC, Orietta Spinelli, BiolSC, Alberto Bosi, MD, Filippo Marmont, MD, Giuseppe Rossi, Sergio Cortelazzo, MD, Alessandro Levis, Daniele Mattei, MD, Maria Pogliani Enrico Maria, MD, Anna Maria Scattolin, MD, Massimo Bernardi, MD, Giacomo Gianfaldoni, MD, Ernesta Audisio, MD, Arianna Masciulli, BiolSc, Renato Bassan, MD, Alessandro Rambaldi, MD

Blood (2013) 122 (21): 2648.

DOI: https://doi.org/10.1182/blood.V122.21.2648.2648

Published: 2013

NARROW

Molecular Characterization of Diffuse Large B-Cell Lymphoma Associated to Hepatitis C Virus Infection

Targeted Next Generation Sequencing Reveals Molecular Heterogeneity in Non-CLL Clonal B-Cell Lymphocytosis

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Early Progression As a Predictor of Survival in Marginal Zone Lymphomas: An Analysis from the Prospective International NF10 Study By Fondazione Italiana Linfomi

Molecular Subtypes of Splenic Marginal Zone Lymphoma (SMZL) Are Associated with Distinct Pathogenic Mechanisms and Outcomes - Interim Analysis of the IELSG46 Study

Hepatitis B Virus Associated B-Cell Non-Hodgkin Lymphoma in Non-Endemic Areas

Real Life Data on Clinical Aspects and Treatment of Marginal Zone Lymphoma: An Analysis from the NF10 Project, an International, Prospective, Observational Study of the Fondazione Italiana Linfomi

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection

Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era

Pattern of Care in Indolent Non Follicular Lymphoma: A Report from NF10 Project, an International, Prospective, Observational Study Coordinated By the Fondazione Italiana Linfomi

Childhood myelodysplastic syndrome associated with an acquired Bernard-Soulier–like platelet dysfunction

The Long-Term Outcome Of Adult Patients With Acute Myeloid Leukemia NPM+ and FLT3/ITD- Is Not Significantly Improved By The Application Of An Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only